Por: Ars Technica Science May 17, 2023
Navigate Filter by topic Settings Front page layout Site theme - May 16, 2023 11:26 pm UTC / The flu virus, showing the H and N proteins on its surface. An mRNA-based flu vaccine designed to offer long-lasting protection against a broad range of influenza viruses is now in a phase I clinical trial, . Further ReadingThe trial brings the remarkable success of the mRNA vaccine platform to the long-standing efforts to develop a universal flu... + full article
The Boston Globe USA Nation April 28, 2023
Anti-vaccine advocates have for years used foreboding imagery of syringes to paint immunizations as dark and dangerous. But recent vaccine conspiracy theories are casting an air of fear around more mundane things — like cows and lettuce.In widespread posts online in recent... + más
What Are the Duties of A Trustee? | Forbes
Shaikin: Baseball embracing the 'flukes' and plenty of added revenue this postseason | Los Angeles Times
ABC News USA Tech April 26, 2023
ABC News USA Health April 25, 2023
Associated Press USA Science April 25, 2023
Los Angeles Times USA Science April 25, 2023
Anti-vaccine advocates have for years used foreboding imagery of syringes to paint immunizations as dark and dangerous. But recent vaccine conspiracy theories are casting an air of fear around more mundane things — like cows and lettuce. In widespread posts online in recent... + más
What we know about the new COVID-19 variant XBB | The Boston Globe
Amid conspiracy theories circulating online, experts confirm COVID vaccines are not in the food supply | The Boston Globe
The Daily Beast USA World January 02, 2023
The novel coronavirus could help us cure cancer. Well, certain cancers.The gave the pharmaceutical industry the push it needed to finally finish developing so that companies such as could use the tech for its COVID vaccines.Now the pharmaceutical industry is using the same mRNA... + más
Cancer vaccine may be ready by 2030, say founders of COVID vaccine makers BioNTech | ABC News
What is metastatic breast cancer? | WPLG Local 10
ABC7 USA Health October 18, 2022
in an interview over the weekend. Her husband, professor Ugur Sahin, with whom she cofounded the German pharmaceutical company BioNTech, said he thought cancer vaccines could be widely available before 2030.The husband-and-wife duo founded BioNTech in 2008 originally to develop... + más
In Boston visit, BioNTech’s leaders say the pandemic isn’t close to being over | The Boston Globe
About iurex | Privacy Policy | Disclaimer |